Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Ensuring optimal efficacy is a critical component of patient safety in clinical trials, requiring careful anticipation and prevention of unfavorable impacts on enrolled patients.
Ensuring optimal efficacy is an important facet of patient safety during the conduct of a clinical trial, if, by "safety," we mean the anticipation, prevention, and assessment of any event that can have an unfavorable impact on the enrolled patients. This article addresses what could be termed the "nonsafety" aspects of safety during clinical trials, with a focus on situations in which we, as drug developers and clinical investigators, can err and thereby put our study patients at an unanticipated and unintended risk for a poor outcome. Approaches to mitigating the safety risk of efficacy are also discussed.
No takes yet. Share an insight, caveat, or question.
George H. Talbot (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: